Invention Grant
- Patent Title: RNA-induced translational silencing and cellular apoptosis
- Patent Title (中): RNA诱导的翻译沉默和细胞凋亡
-
Application No.: US12990493Application Date: 2009-05-01
-
Publication No.: US08173616B2Publication Date: 2012-05-08
- Inventor: Paul Anderson , Satoshi Yamasaki
- Applicant: Paul Anderson , Satoshi Yamasaki
- Applicant Address: US MA Boston
- Assignee: The Brigham and Women's Hospital, Inc.
- Current Assignee: The Brigham and Women's Hospital, Inc.
- Current Assignee Address: US MA Boston
- Agency: Law Office of Michael A. Sanzo, LLC
- International Application: PCT/US2009/002718 WO 20090501
- International Announcement: WO2009/134443 WO 20091105
- Main IPC: A61K31/70
- IPC: A61K31/70 ; C07H21/02 ; C07H21/04
Abstract:
The invention is directed to RNA molecules that can be used to inhibit protein synthesis and to induce cells to undergo apoptosis. It also includes pharmaceutical compositions containing the RNAs that can be used in treating or preventing tumors; abnormal dermatological growths and viral infections.
Public/Granted literature
- US20110046209A1 RNA-Induced Translational Silencing and Cellular Apoptosis Public/Granted day:2011-02-24
Information query
